Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175.

Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175.

Shortened current direct-acting antiviral (DAA) therapies while less expensive, have not provided satisfactory efficacy in naïve cirrhotics, treatment experienced non-cirrhotics or even genotype-3 (GT3)-infected patients. Since DAA regimens consist of the same classes of inhibitors-NS5A (NS5Ai) and...

Full description

Bibliographic Details
Main Authors: Philippe A Gallay, Udayan Chatterji, Michael D Bobardt, Zhengyu Long, Shengli Zhang, Zhuang Su
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0152036

Similar Items

Similar Items